Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs
On August 3, Ocular Therapeutix (NASDAQ:OCUL) reported second-quarter 2026 financial results that read as much like a regulatory…
FDA pilot offers generative AI medical devices a path to patients
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech;…
FDA approves new Alzheimer’s blood test that family doctors can order
FDA approves new Alzheimer’s blood test for people over 55. Here’s what it can — and can’t —…
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
The recent breakout of Moderna reminded investors that AI stocks aren’t the only destination to make money. Healthcare…
FDA warning over trendy longevity supplement after hospitalizations
The quest for longevity is leaving some in worse shape than when they started. The FDA has issued…
Modern medicine failed her. She turned to toad venom instead
Sly Young doesn’t always believe in “woo-woo” medicine. But she comes from a long line of traditional healers…
Beware the ‘unholy trinity’ of supplements
That bottle in your medicine cabinet may deserve a closer look. Nearly three-quarters of American adults take dietary…
Misbranding, storage lapses: FDA cancels Cipla Pune unit’s drug licence over Reactin Plus violations | Mumbai News
The Maharashtra Food and Drug Administration has revoked Cipla’s licenses to sell Reactin Plus Tablets MUMBAI: The Maharashtra…
FDA Announces Recall of Thyroid Medicine Due to Potential “Super Potency”
If you take medication for an underactive thyroid, check your bottle right away. The U.S. Food and Drug…
The $3,000 mattress cover company that billionaires love wants to become a healthcare company
Eight Sleep, the startup behind the $2,999 mattress cover that puts both Elon Musk and Mark Zuckerberg to…
For Narcoleptics, a 'New Chapter' – Newser
For Narcoleptics, a ‘New Chapter’ NewserFDA Approves First Drug to Treat a Cause of Narcolepsy Time MagazineThis Newly Approved Narcolepsy…
Lawsuit claims link between GLP-1 weight loss drugs and blindness – Boston 25 News
mASS. — A multi-district lawsuit involving more than 130 cases is before a Philadelphia judge, alleging that popular…